IL17A and myasthenia gravis: IL-17 functions as the primary effector of Th17 cells and has been reported to be up-regulated and associated with clinical parameters of MG (22, 23), in line with the findings of this study, where IL-17 levels were significantly higher in patients with unstable MG compared to healthy controls.